<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translation

Grace R. Anderson(Duke University), Kris C. Wood(Duke University), Jim C. Leeds(Duke University), Lorin Crawford(Microsoft (United States)), Alexander P. Yllanes(Duke University), Suzanne E. Wardell(Duke University), Shannon J. McCall(Duke Medical Center), Elizabeth K. Zieser-Misenheimer(Duke University), Ryan S. Soderquist(Duke University), Donald P. McDonnell(Duke University), Holly M. Alley(Duke University), Peter Winter(Duke University), Elizabeth M. Stein(Duke University), Victoria O. Haney(Duke University), Merve Çakır(University of California, San Francisco), Jennifer P. Tingley(Duke University), Pallavi S. Shankar(Duke University), Kimberly Blackwell(Duke University), Daniel P. Nussbaum(Memorial Sloan Kettering Cancer Center)
Science Translational Medicine
December 14, 2016
Cited by 58


Related Papers